Total Payments
$14,779
2024 Payments
$658.59
Companies
56
Transactions
792
Medicare Patients
2,370
Medicare Billing
$501,681
Payment Breakdown by Category
Food & Beverage$13,097 (88.6%)
Travel$1,673 (11.3%)
Education$9.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,097 | 787 | 88.6% |
| Travel and Lodging | $1,673 | 3 | 11.3% |
| Education | $9.45 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,620 | 38 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $1,950 | 147 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $1,094 | 78 | $0 (2021) |
| Amgen Inc. | $744.84 | 24 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $743.50 | 53 | $0 (2024) |
| PFIZER INC. | $714.50 | 95 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $679.73 | 42 | $0 (2024) |
| ABBVIE INC. | $588.48 | 25 | $0 (2024) |
| Indivior Inc. | $498.36 | 21 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $431.76 | 37 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $658.59 | 35 | Collegium Pharmaceutical, Inc. ($344.87) |
| 2023 | $953.43 | 58 | Collegium Pharmaceutical, Inc. ($378.23) |
| 2022 | $1,521 | 82 | Collegium Pharmaceutical, Inc. ($394.39) |
| 2021 | $1,719 | 102 | Collegium Pharmaceutical, Inc. ($408.32) |
| 2020 | $1,472 | 91 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($245.01) |
| 2019 | $2,465 | 154 | BioDelivery Sciences International, Inc. ($268.49) |
| 2018 | $1,976 | 115 | BioDelivery Sciences International, Inc. ($302.84) |
| 2017 | $4,014 | 155 | BOSTON SCIENTIFIC CORPORATION ($1,963) |
All Payment Transactions
792 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Opioid Analgesic | ||||||
| 11/06/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $32.84 | General |
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| Category: Opioid Analgesic | ||||||
| 10/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: Opioid Analgesic | ||||||
| 09/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: Opioid Analgesic | ||||||
| 09/03/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.63 | General |
| Category: Opioid Analgesic | ||||||
| 08/12/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $2.53 | General |
| Category: Opioid Analgesic | ||||||
| 07/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Opioid Analgesic | ||||||
| 07/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.79 | General |
| Category: Opioid Analgesic | ||||||
| 06/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $5.96 | General |
| Category: Opioid Analgesic | ||||||
| 06/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Opioid Analgesic | ||||||
| 05/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $24.51 | General |
| Category: Opioid Analgesic | ||||||
| 05/07/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Opioid Analgesic | ||||||
| 04/30/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Central Nervous System | ||||||
| 04/22/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.97 | General |
| Category: Opioid Analgesic | ||||||
| 04/17/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $0.78 | General |
| Category: Opioid Analgesic | ||||||
| 04/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| Category: Opioid Analgesic | ||||||
| 03/26/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $10.76 | General |
| Category: Opioid Analgesic | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 474 | 2,239 | $316,720 | $95,988 |
| 2022 | 9 | 518 | 2,906 | $396,475 | $126,031 |
| 2021 | 12 | 679 | 3,459 | $450,265 | $142,521 |
| 2020 | 13 | 699 | 2,325 | $519,530 | $137,142 |
Total Patients
2,370
Total Services
10,929
Medicare Billing
$501,681
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 489 | $88,020 | $46,115 | 52.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 39 | 64 | $70,200 | $13,947 | 19.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 36 | 193 | $48,250 | $8,925 | 18.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 38 | 67 | $34,650 | $6,605 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 91 | $10,010 | $5,952 | 59.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 66 | $16,500 | $3,424 | 20.7% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 11 | 14 | $12,600 | $3,024 | 24.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 12 | 17 | $16,200 | $2,232 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,950 | $2,042 | 41.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 26 | 32 | $2,560 | $1,944 | 75.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 77 | 1,170 | $11,700 | $978.60 | 8.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 18 | $1,080 | $799.68 | 74.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 668 | $120,240 | $64,005 | 53.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 54 | 91 | $95,400 | $19,950 | 20.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 38 | 250 | $62,500 | $12,250 | 19.6% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 50 | 99 | $44,550 | $9,467 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 118 | $12,980 | $7,773 | 59.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $10,450 | $4,870 | 46.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 36 | 83 | $20,750 | $4,221 | 20.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 12 | 16 | $14,175 | $2,161 | 15.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 95 | 1,543 | $15,430 | $1,334 | 8.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 170 | 670 | $120,600 | $67,270 | 55.8% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 59 | 97 | $99,900 | $21,266 | 21.3% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 44 | 211 | $52,750 | $10,402 | 19.7% |
| 64484 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, each additional level | Office | 2021 | 56 | 105 | $48,150 | $10,102 | 21.0% |
About Dr. Todd Handel, MD
Dr. Todd Handel, MD is a Pain Medicine healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518067883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Handel, MD has received a total of $14,779 in payments from pharmaceutical and medical device companies, with $658.59 received in 2024. These payments were reported across 792 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,097).
As a Medicare-enrolled provider, Handel has provided services to 2,370 Medicare beneficiaries, totaling 10,929 services with total Medicare billing of $501,681. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Pawtucket, RI
- Active Since 09/25/2006
- Last Updated 07/08/2007
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1518067883
Products in Payments
- XTAMPZA (Drug) $1,859
- PRECISION (Device) $1,838
- Aimovig (Biological) $744.84
- RELISTOR (Drug) $601.65
- BELBUCA (Drug) $568.89
- AJOVY (Biological) $568.21
- LYRICA (Drug) $534.11
- SUBLOCADE (Drug) $498.36
- Movantik (Drug) $481.68
- BUNAVAIL 2.1 mg 30-count box (Drug) $451.44
- Horizant (Drug) $427.81
- UBRELVY (Drug) $304.77
- QULIPTA (Drug) $297.85
- Nucynta (Drug) $261.12
- WaveWriter Alpha Prime 16 (Device) $240.42
- Zilretta (Drug) $214.43
- Lucemyra/Lofexidine (Drug) $203.02
- Senza Spinal Cord Stimulation System (Device) $193.35
- SPECTRA WAVEWRITER (Device) $192.56
- RELISTOR ORAL (Drug) $188.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.